首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1964256

传染性鼻炎疫苗市场规模、份额和成长分析：按疫苗类型、给药途径、应用领域、最终用户、分销管道、地区和行业预测，2026-2033年

Infectious Coryza Vaccine Market Size, Share, and Growth Analysis, By Vaccine Type, By Administration Route, By Application Area, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2024年全球传染性鼻炎疫苗市值为8.182亿美元，预计将从2025年的8.7793亿美元成长到2033年的15.4261亿美元。预测期（2026-2033年）的复合年增长率预计为7.3%。

全球传染性鼻炎疫苗市场对于防治家禽副鸡桿菌感染疾病至关重要，该感染会显着影响鸡蛋产量和禽群健康。在全球动物保健公司的推动下，该市场已从小小规模解决方案转向广泛应用的灭活疫苗和减毒活病毒疫苗。家禽养殖业的扩张增加了感染风险，也提高了常规疫苗接种的经济需求。旨在减少抗生素使用的监管政策调整进一步加速了疫苗的普及，尤其是在欧洲和亚洲部分地区，这与公共卫生政策和疫苗推广部署的扩大相一致。疫苗製剂和物流方面的技术进步为不同血清型的客製化解决方案创造了机会。人工智慧透过优化抗原选择和加速候选疫苗设计来促进疫苗研发，最终提高疫苗的有效性和市场可靠性。

全球传染性鼻炎疫苗市场驱动因素

随着全球家禽数量的增长，禽群对传染性鼻炎的易感性也日益增加，凸显了疫苗接种等预防措施的迫切需求。家禽养殖户致力于维护禽群健康，以提高生产力并减少损失，这促使疫苗接种计划得到广泛实施，并加大对免疫措施的投入。兽医服务和咨询网路的建议进一步强调了积极疫苗接种策略的重要性，从而推动了市场需求。这种持续的需求促使生产商扩大产能、丰富疫苗产品种类并加强推广活动，透过提高疫苗的可及性和普及率，促进了全球传染性鼻炎疫苗市场的成长。

全球传染性鼻炎疫苗市场面临的限制因素

全球传染性鼻炎疫苗市场面临诸多限制因素，主要源自于各地监管核准流程的复杂性。这些冗长繁琐的程序导致产品上市延迟，新疫苗供应迅速短缺，阻碍市场成长。製造商必须应对各种不同的标准和繁琐的文件要求，导致研发週期延长，合规挑战加剧。这种环境既会阻碍中小企业采用创新配方，也会限制现有产品的市场推广。因此，创新应用缓慢，加上终端用户谨慎的采购惯例，共同限制了整体市场扩张。

全球传染性鼻炎疫苗市场趋势

由于综合农场健康计画的实施，全球传染性鼻炎疫苗市场正经历显着成长。生产者越来越重视全面预防保健，将疫苗接种、生物安全措施和营养管理协同结合。兽医和服务供应商实施协调的疫苗接种计划和农场监测，进一步推动了这一趋势，从而提升了疫苗在畜牧业健康策略中的价值。对动物福利、稳定生产力和长期降低疾病风险的关注，推动了客製化疫苗配方和综合支持服务的应用。因此，这种动态环境正在加强与供应商的关係，并在各种家禽养殖场中建立可预测的采购模式。

北美洲
- 我们
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场公司采取的策略
近期市场趋势
企业市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 按细分市场进行企业市占率分析
- 2023-2025年营收年比比较

主要企业简介

Zoetis Inc.
Merck Animal Health
Elanco Animal Health
Boehringer Ingelheim Animal Health
Vetoquinol
Hipra
Neogen Corporation
IDT Biologika
Intervet International BV
Phibro Animal Health
Virbac
Biovet
Kemin Industries
Alltech
Cegelec
Jansen Vaccines
Chengdu Hightop Biopharmaceutical
Inovio Pharmaceuticals
Paragon Bioservices
Animal Biotech Industries

结论与建议

简介目录

Product Code: SQMIG35J2196

Global Infectious Coryza Vaccine Market size was valued at USD 818.2 Million in 2024 and is poised to grow from USD 877.93 Million in 2025 to USD 1542.61 Million by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The global infectious coryza vaccine market is essential for combating Avibacterium paragallinarum infections in poultry, significantly impacting egg production and flock health. The market has transitioned from small-scale solutions to widely accessible inactivated and live attenuated vaccines propelled by global animal health firms. Growing poultry production intensifies transmission risks, thereby increasing the economic imperative for routine vaccination. Regulatory shifts aiming to reduce antibiotic use further incentivize vaccine adoption, particularly in Europe and parts of Asia, where public health policies align with increased vaccine implementation. Technological advancements in vaccine formulation and logistics create opportunities for customized solutions targeting various serovars. AI enhances vaccine development by refining antigen selection and expediting candidate design, ultimately improving the efficacy and reliability of vaccines in the marketplace.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infectious Coryza Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infectious Coryza Vaccine Market Segments Analysis

Global infectious coryza vaccine market is segmented by vaccine type, administration route, application area, end user, distribution channel and region. Based on vaccine type, the market is segmented into Inactivated Vaccine, Live Attenuated Vaccine and Recombinant Vaccine. Based on administration route, the market is segmented into Intramuscular Injection, Subcutaneous Injection and Nasal Spray. Based on application area, the market is segmented into Poultry Farms, Veterinary Clinics and Research Laboratories. Based on end user, the market is segmented into Commercial Producers, Small Scale Farmers and Research Institutions. Based on distribution channel, the market is segmented into Online Sales, Direct Sales and Distributors and Wholesalers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infectious Coryza Vaccine Market

The increasing global poultry population heightens the vulnerability of flocks to infectious coryza, thereby intensifying the perceived necessity for preventive measures such as vaccination. Poultry producers focus on maintaining flock health to boost productivity and minimize losses, leading to a wider implementation of vaccination programs and more robust investment in immunization practices. Recommendations from veterinary services and advisory networks further emphasize the importance of proactive vaccination strategies, bolstering market demand. This ongoing necessity prompts manufacturers to expand production capabilities, diversify their vaccine offerings, and enhance outreach efforts, collectively contributing to the growth of the global infectious coryza vaccine market through improved accessibility and adoption.

Restraints in the Global Infectious Coryza Vaccine Market

The global market for infectious coryza vaccines faces significant constraints due to intricate regulatory approval processes that vary by region. These extended and complex procedures often lead to delays in product launches and limit the swift availability of new vaccines, hindering market growth. Manufacturers must navigate diverse standards and extensive documentation requirements, which lengthen development timelines and elevate compliance challenges. This environment can deter smaller firms from introducing innovative formulations, while also confining the market reach of existing products. Consequently, the slow pace of innovation adoption and cautious procurement practices by end users collectively temper overall market expansion.

Market Trends of the Global Infectious Coryza Vaccine Market

The Global Infectious Coryza Vaccine market is experiencing significant growth driven by the adoption of integrated farm health programs. Producers are increasingly prioritizing comprehensive preventative care that synergizes vaccination, biosecurity measures, and nutrition management. This trend is supported by veterinarians and service providers who are implementing coordinated vaccination schedules and on-farm monitoring, thereby enhancing the perceived value of vaccines in herd health strategies. The emphasis on animal welfare, productivity stability, and long-term disease risk reduction is fostering the adoption of tailored vaccine formulations and comprehensive support services. Consequently, this dynamic landscape is strengthening supplier relationships and establishing predictable procurement patterns across various poultry operations.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Infectious Coryza Vaccine Market Size by Vaccine Type & CAGR (2026-2033)

Market Overview
Inactivated Vaccine
Live Attenuated Vaccine
Recombinant Vaccine

Global Infectious Coryza Vaccine Market Size by Administration Route & CAGR (2026-2033)

Market Overview
Intramuscular Injection
Subcutaneous Injection
Nasal Spray

Global Infectious Coryza Vaccine Market Size by Application Area & CAGR (2026-2033)

Market Overview
Poultry Farms
Veterinary Clinics
Research Laboratories

Global Infectious Coryza Vaccine Market Size by End User & CAGR (2026-2033)

Market Overview
Commercial Producers
Small Scale Farmers
Research Institutions

Global Infectious Coryza Vaccine Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Online Sales
Direct Sales
Distributors and Wholesalers

Global Infectious Coryza Vaccine Market Size & CAGR (2026-2033)

North America (Vaccine Type, Administration Route, Application Area, End User, Distribution Channel)
- US
- Canada
Europe (Vaccine Type, Administration Route, Application Area, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Vaccine Type, Administration Route, Application Area, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Vaccine Type, Administration Route, Application Area, End User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Vaccine Type, Administration Route, Application Area, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Zoetis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetoquinol
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hipra
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDT Biologika
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intervet International B.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phibro Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biovet
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kemin Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alltech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cegelec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jansen Vaccines
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chengdu Hightop Biopharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inovio Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Paragon Bioservices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Animal Biotech Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments